# Attenuation of microglial aryl hydrocarbon receptor alters astrocyte activation and chronic pain sensitization in aging

**Authors:** Jia-Xiao Sun, Ying Huang, Juan-Juan Zheng, Wen-Qin Xie

PMC · DOI: 10.1515/biol-2025-1261 · Open Life Sciences · 2026-02-02

## TL;DR

This study shows that reduced AHR in aged mice's microglia increases astrocyte activation and chronic pain.

## Contribution

The novel finding is that microglial AHR regulates astrocyte activation and chronic pain in aging.

## Key findings

- AHR expression in spinal dorsal horn microglia is significantly lower in aged mice.
- Reduced microglial AHR enhances astrocyte activation and inflammation.
- Lower AHR in aged mice contributes to prolonged pain sensitization.

## Abstract

This study aims to examine differences in aryl hydrocarbon receptor (AHR) expression between microglia in aged and adult mice and to investigate the impact of microglial AHR attenuation on chronic pain sensitization. Immunofluorescence staining was performed to assess AHR expression in microglia. BV2 microglial cells were treated with lipopolysaccharides (LPS), the AHR agonist FICZ, and the AHR antagonist CH223191. The resulting supernatant was used to culture C8-DIA astrocytes, and inflammatory factor levels were quantified using quantitative real-time polymerase chain reaction. AHR expression in spinal dorsal horn microglia was significantly lower in aged mice compared to adult mice. Furthermore, microglial AHR expression was found to regulate astrocyte activation. AHR expression in spinal dorsal horn microglia is markedly reduced in aged mice. Activated microglia with diminished AHR expression induce astrocytes more strongly and enhance astrocyte-mediated inflammation, contributing to prolonged hyperalgesia in aged mice.

## Linked entities

- **Genes:** AHR (aryl hydrocarbon receptor) [NCBI Gene 196]
- **Chemicals:** FICZ (PubChem CID 1863), CH223191 (PubChem CID 3091786)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** Vegfb (vascular endothelial growth factor B) [NCBI Gene 22340] {aka VEGF-B, Vrf}, Tlr4 (toll-like receptor 4) [NCBI Gene 21898] {aka Lps, Ly87, Ran/M1, Rasl2-8}, Tgfa (transforming growth factor alpha) [NCBI Gene 21802] {aka wa-1, wa1}, Nfkb1 (nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105) [NCBI Gene 18033] {aka NF-KB1, NF-kappaB, NF-kappaB1, p105, p50, p50/p105}, Iba1 (induction of brown adipocytes 1) [NCBI Gene 114737], Ccl2 (C-C motif chemokine ligand 2) [NCBI Gene 20296] {aka HC11, JE, MCAF, MCP-1, MCP1, SMC-CF}, Il1b (interleukin 1 beta) [NCBI Gene 16176] {aka IL-1beta, Il-1b}, Egfr (epidermal growth factor receptor) [NCBI Gene 13649] {aka 9030024J15Rik, Erbb, Errb1, Errp, Wa5, wa-2}, Cx3cr1 (C-X3-C motif chemokine receptor 1) [NCBI Gene 13051] {aka mCX3CR1}, Il6 (interleukin 6) [NCBI Gene 16193] {aka Il-6}, Flt1 (FMS-like tyrosine kinase 1) [NCBI Gene 14254] {aka Flt-1, VEGFR-1, VEGFR1, sFlt1}, Relb (Relb proto-oncogene, NFKB subunit) [NCBI Gene 19698] {aka shep}, Nos2 (nitric oxide synthase 2, inducible) [NCBI Gene 18126] {aka MAC-NOS, NOS-II, Nos-2, Nos2a, i-NOS, iNOS}, Tnf (tumor necrosis factor) [NCBI Gene 21926] {aka DIF, TNF-a, TNF-alpha, TNFSF2, TNFalpha, Tnfa}, Ahr (aryl-hydrocarbon receptor) [NCBI Gene 11622] {aka Ah, Ahh, Ahre, In, bHLHe76}, Gapdh (glyceraldehyde-3-phosphate dehydrogenase) [NCBI Gene 14433] {aka Gapd}, Cyp1a1 (cytochrome P450, family 1, subfamily a, polypeptide 1) [NCBI Gene 13076] {aka AHH, AHRR, CP11, CYPIA1, P450-1}, Cyp1b1 (cytochrome P450, family 1, subfamily b, polypeptide 1) [NCBI Gene 13078] {aka CP1B, CYPIB1, P4501b1}
- **Diseases:** neuroinflammation (MESH:D000090862), autoimmune inflammation (MESH:D007249), constriction injury (MESH:D014947), pain (MESH:D010146), CCI (MESH:D020208), acute (MESH:D000208), autoimmune demyelination (MESH:D020278), age (MESH:D019588), nerve injury (MESH:D000080902), multiple sclerosis (MESH:D009103), hyperalgesia (MESH:D006930), inflammatory cytokines (MESH:D000080424), Chronic pain (MESH:D059350), EAE (MESH:D004681), NPP (MESH:D009437), nerve constriction (MESH:D015877), hypersensitivity (MESH:D004342)
- **Chemicals:** pentobarbital sodium (MESH:D010424), DMEM (-), DAPI (MESH:C007293), paraformaldehyde (MESH:C003043), CH223191 (MESH:C511621), sucrose (MESH:D013395), LPS (MESH:D008070), 6-Formylindolo [3,2-b] carbazole (MESH:C111855)
- **Species:** Mus musculus (house mouse, species) [taxon 10090]
- **Cell lines:** C8-D1A — Mus musculus (Mouse), Spontaneously immortalized cell line (CVCL_6379), C8-DIA — Homo sapiens (Human), Melanoma, Cancer cell line (CVCL_VV73), BV2 — Mus musculus (Mouse), Transformed cell line (CVCL_0182)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12917549/full.md

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12917549/full.md

## References

20 references — full list in the complete paper: https://tomesphere.com/paper/PMC12917549/full.md

---
Source: https://tomesphere.com/paper/PMC12917549